Navigation Links
Doctors Without Borders and DNDi: Millions of Patients Still Waiting for Medical “Breakthroughs” Against Neglected Diseases
Date:12/14/2012

d Dr. Unni Karunakara, MSF's international president. “People are still dying of archaic diseases. Doctors and nurses are still handcuffed by the shortcomings of available medicines, forced to treat their patients with decades-old, often brutal drugs. As we speak, there are drug-resistant TB patients enduring two years on an absolutely horrific course of treatment—debilitating nausea and pain, depression, social isolation, hearing loss, and even psychosis, are just some of the few side effects they can have while on these medicines. Our patients are still waiting for real scientific breakthroughs.”

The two-day conference, Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations, also hosted by the Mount Sinai School of Medicine’s Global Health Program, will look at the progress and shortcomings of the last decade of medical R&D to fight neglected diseases—a period during which there has been an increase in new neglected disease R&D initiatives and funders—and will focus in particular on the need to accelerate development and delivery of new health technologies to fight Chagas disease and drug-resistant tuberculosis (DR-TB). It will also examine the need for

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management
2. Ellmans Pelleve™ Wrinkle Reduction System featured in "Sexy Eyes" segment on The Doctors
3. Electronics without current: Finnish team to research the future of nanoelectronics
4. 3-D movies in your living room -- without the glasses
5. NineSigma Partners with Scientists Without Borders to Find New Sustainable Packaging for Micronutrient Powders that Combat Malnutrition
6. New silk technology preserves heat-sensitive drugs for months without refrigeration
7. In chemical reactions, water adds speed without heat
8. New Organization Plans to Use Independent Peer Review to Put Millions of Hours Back into Research
9. Millions of DNA switches that power human genomes operating system are discovered
10. CureLauncher is a New Website That Connects Patients to Trials Across the U.S.
11. Cell Therapeutics Reports on Cooperative Group Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... N.J. , March 30, 2015  New Jersey ... innovation projects in the state of New ... next round of grant funding, announced James M. ... Jersey Health Foundation Research Grants program, an additional $500,000 ... each to fund early stage research projects that demonstrate ...
(Date:3/30/2015)... , March 30, 2015 CASI Pharmaceuticals, ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a commercial focus on ... and Drug Administration (CFDA) has approved the Company,s application ... ovarian clear cell carcinoma (OCCC) patients for its proprietary ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
(Date:3/30/2015)... (PRWEB) March 29, 2015 A two-day ... United States and plenary talks by four leading photonics ... Optics + Optoelectronics next month in Prague, Czech ... in 17 conferences alongside a two-day exhibition. Sponsored by ... , the event will run 13-16 April in the ...
Breaking Biology Technology:New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3
... NGSX ), a biopharmaceutical company focused on developing ... results for its fourth quarter and year-end 2007 on ... conference call to review the results will begin at ... and will be hosted by Anthony DiTonno,President and Chief ...
... Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS), a biotechnology Company ... targeting the chronic inflammation,underlying cardiovascular and neurological disease, ... and Special Meeting of Shareholders,being held at the ... at 4:30 p.m. ET., To participate via ...
... Md., March 18 Martek Biosciences,(Nasdaq: MATK ) ... with,life,sDHA(TM), its patented, vegetarian form of DHA omega-3 for ... bread with vegetarian DHA,Oroweat 9 Grain Bread with life,sDHA ... in the Pacific Northwest, California, Arizona,and Nevada., "This ...
Cached Biology Technology:NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results 2NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results 3Vasogen to Webcast its Annual Meeting 2Vasogen to Webcast its Annual Meeting 3Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 2Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 3
(Date:3/10/2015)... March 10, 2015  Continuing its 167-year history of ... Schlemmer introduces The Eye Scanning Password Authenticator , ... access to secure websites or sensitive data. ... at international borders, the device has a small camera ... of the iris, converting them into an encrypted ID ...
(Date:3/10/2015)... Utah , March 10, 2015   Tute ... interpretation, has been selected by next-generation sequencing company ... of whole exome and targeted gene panel interpretation. ... provider, has adopted the most current technologies to support ... genetic research. The company offers two types of exome ...
(Date:3/5/2015)... 5, 2015 In Brazil , ... already using these solutions and 42 percent planning to invest ... approximately 25 percent of the companies will be investing in ... majority of companies in the region are currently opting for ... model will command significant attention in the coming years. This ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
... EUREKA project E! 4104 ECOPROMAT has developed a ... protection against the spread of contagious animal diseases such ... and food production. Soaked with disinfectant solution, the matting ... shoes and boots of personnel. As it is made ...
... imitated Mother Nature by developing, for the first ... the tiny, hair-like structures through which organisms derive ... the new material isn,t exactly like cilia, it ... researchers to control it and opening unlimited possibilities ...
... the little engine that could, the University of Nevada, ... is chugging along, dwarfed by the million-gallon tanks, pipes ... where, ultimately, the plant,s electrical power could be supplied ... "We are very pleased with the results of the ...
Cached Biology News:A biological solution to animal pandemics 2A biological solution to animal pandemics 3A biological solution to animal pandemics 4Cilia revolution 2University of Nevada, Reno demonstrates successful sludge-to-power research 2University of Nevada, Reno demonstrates successful sludge-to-power research 3
... double stranded RNA (dsRNA) has been shown ... group of organisms as well as insect ... the inhibition of protein expression by utilizing ... RNA (mRNA). Attempts to induce RNA interference ...
... is an easy-to-use siRNA transfection reagent that ... genes in a variety of cell lines. ... an optimized, straightforward protocol. High levels of ... following transfection of 20 to 100 nM ...
... double stranded RNA (dsRNA) has been shown ... group of organisms as well as insect ... the inhibition of protein expression by utilizing ... RNA (mRNA). Attempts to induce RNA interference ...
... is used to distinguish collagen from muscle ... System. The Trichrome stain is often used ... and to identify an increase in collagenous ... muscle is stained red, collagen - blue, ...
Biology Products: